Alkem Laboratories Limited a pharmaceutical company that engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products.
Business Segments
The company operates through Prescription Medications, Generic D…
Analysis
Middle-of-the-road
Alkem Laboratories Limited is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.
The price is expensive. You pay 28.2× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 11% yearly growth; analysts expect 10%. The price, in other words, assumes less than the experts do.
The trajectory is moderate and the balance sheet is sturdy. The company scores 13/20 on our value-creation score: creating some value.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202347
42
2023202420252026
All-time high
88
Jan 2024
All-time low
22
Jan 2025
Average rank
56
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
32
48
50
59
Price/Earnings
44
58
38
64
Price/Book
28
45
44
54
Dividend Yield
65
56
47
62
Value (overall)
48
61
51
71
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.